NasdaqGS - Delayed Quote USD
Indivior PLC (INDV)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-227,000.00
-315,000.00
-4,000.00
353,000.00
-193,000.00
--
Investing Cash Flow
32,000.00
-98,000.00
-223,000.00
-14,000.00
-4,000.00
--
Financing Cash Flow
-96,000.00
-46,000.00
-100,000.00
-94,000.00
-10,000.00
--
End Cash Position
301,000.00
316,000.00
774,000.00
1,102,000.00
858,000.00
--
Capital Expenditure
-52,000.00
-53,000.00
-6,000.00
-34,000.00
-4,000.00
--
Issuance of Capital Stock
3,000.00
4,000.00
2,000.00
1,000.00
1,000.00
--
Issuance of Debt
--
--
--
250,000.00
--
--
Repayment of Debt
-2,000.00
-12,000.00
-3,000.00
-236,000.00
-4,000.00
--
Repurchase of Capital Stock
-92,000.00
-33,000.00
-90,000.00
-101,000.00
--
--
Free Cash Flow
-279,000.00
-368,000.00
-10,000.00
319,000.00
-197,000.00
--
12/31/2019 - 12/29/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LFCR Lifecore Biomedical, Inc.
5.25
+0.77%
PETQ PetIQ, Inc.
30.97
+0.13%
PAHC Phibro Animal Health Corporation
23.65
-1.74%
ORGO Organogenesis Holdings Inc.
3.1100
-1.58%
ANIK Anika Therapeutics, Inc.
24.44
-2.47%
COLL Collegium Pharmaceutical, Inc.
36.46
-5.15%
GHSI Guardion Health Sciences, Inc.
3.2300
0.00%
ETON Eton Pharmaceuticals, Inc.
8.44
+1.08%
HCM HUTCHMED (China) Limited
20.85
-0.24%
6785.TWO Alar Pharmaceuticals Inc.
167.50
-1.47%